Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6479]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Transarterial chemoembolization with or without sorafenib for intermediate...
Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an...
Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma ( Prof Guohong Han - Xijing Hospital, Fourth Military Medical University, Xi'an, China )
31 May 2015
Ibrutinib combination regimen shows substantial benefits in relapsed CLL
Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
Ibrutinib combination regimen shows substantial benefits in relapsed CLL ( Dr Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015
Eribulin extends overall survival for patients with advanced liposarcoma and...
Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
30 May 2015
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse...
Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction ( Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA )
29 May 2015
Pembrolizumab for head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab for head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Genomic marker predicts anti-PD-1 response in several cancers
Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Genomic marker predicts anti-PD-1 response in several cancers ( Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
29 May 2015
Pembrolizumab shows promising activity against head and neck cancer
Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab shows promising activity against head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015
Genomic marker predicts anti-PD-1 response in several cancers
Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Genomic marker predicts anti-PD-1 response in several cancers ( Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
29 May 2015
Prostate cancer and pharmacokinetics: Expert discussion
Prof Axel S. Merseburger and Prof Romano Danesi
Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )
26 May 2015
Latest developments in prostate cancer
Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter...
Latest developments in prostate cancer ( Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter Iversen )
20 May 2015
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance
Dr Jonas Nilsson - Umeå University, Umeå, Sweden
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance ( Dr Jonas Nilsson - Umeå University, Umeå, Sweden )
13 May 2015
WIN 2015 hosts 'world class leaders' in personalised therapy
Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA
WIN 2015 hosts 'world class leaders' in personalised therapy ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )
13 May 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation